Hipolin Experiences Revision in Its Stock Evaluation Amidst Strong Market Performance

Dec 10 2024 09:35 AM IST
share
Share Via
Hipolin has recently experienced a notable adjustment in its evaluation, reflecting its impressive performance in the stock market. The company has been added to MarketsMojo's list, highlighting its strong growth potential as it continues to outperform the sector and achieve significant gains over the past week.
Hipolin, a microcap player in the fast-moving consumer goods (FMCG) sector, has recently captured the attention of investors as its stock price soared to a 52-week high on December 10, 2024. Currently trading at Rs. 206.45, Hipolin has experienced a notable upward trajectory over the past week, reflecting a significant increase in its market value.

This impressive performance has not gone unnoticed, with market analysts closely monitoring the stock's movements. Despite receiving a 'Sell' call from MarketsMOJO, Hipolin has managed to outperform its sector by a considerable margin, showcasing a robust performance on the trading floor.

The stock opened with a substantial gain today, reaching an intraday high of Rs. 206.45, which marks a significant rise from its previous closing price. Furthermore, Hipolin's current trading levels exceed its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive outlook for the company's future performance.

In terms of long-term growth, Hipolin has demonstrated remarkable resilience, boasting a 1-year performance of 126.87%, significantly outpacing the Sensex, which recorded a mere 16.75% increase during the same timeframe. This stark contrast underscores Hipolin's strong growth potential and its ability to thrive in a competitive market.

In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Hipolin, reflecting the stock's dynamic performance and market position. As the company continues to gain traction, it has also been added to MarketsMOJO's list, further solidifying its status as a noteworthy contender in the FMCG industry.

With its recent surge and consistent upward trend, Hipolin remains a stock to watch as it navigates the complexities of the market landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News